Sciomics offers high-content analysis services for > 1,000 proteins in a single assay including changes of their post-translational modification status.
Typical applications for the platform are:
• analysis of pathway activity and disease mechanisms
• drug MOA studies
• novel drug targets discovery
• identification and verification of protein biomarkers
Our immuno-based assays guarantee robust and reproducible results which can easily be translated into clinical assays.